Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 228

1.

ROS1-rearranged Non-small-cell Lung Cancer is Associated With a High Rate of Venous Thromboembolism: Analysis From a Phase II, Prospective, Multicenter, Two-arms Trial (METROS).

Chiari R, Ricciuti B, Landi L, Morelli AM, Delmonte A, Spitaleri G, Cortinovis DL, Lamberti G, Facchinetti F, Pilotto S, Verusio C, Chella A, Bonanno L, Galetta D, Cappuzzo F.

Clin Lung Cancer. 2019 Jun 18. pii: S1525-7304(19)30154-8. doi: 10.1016/j.cllc.2019.06.012. [Epub ahead of print]

PMID:
31607443
2.

Erratum to: Ten Years' Experience in Robotic-Assisted Thoracic Surgery for Early Stage Lung Cancer.

Casiraghi M, Galetta D, Borri A, Tessitore A, Romano R, Diotti C, Brambilla D, Maisonneuve P, Spaggiari L.

Thorac Cardiovasc Surg. 2019 Oct 4. doi: 10.1055/s-0039-1698411. [Epub ahead of print] No abstract available.

PMID:
31585465
3.

A Brief Report on Survival After Robotic Lobectomy for Early-Stage Lung Cancer.

Spaggiari L, Sedda G, Maisonneuve P, Tessitore A, Casiraghi M, Petrella F, Galetta D.

J Thorac Oncol. 2019 Aug 19. pii: S1556-0864(19)30666-5. doi: 10.1016/j.jtho.2019.07.032. [Epub ahead of print]

PMID:
31437532
4.

Crizotinib in MET deregulated or ROS1 rearranged pretreated non-small-cell lung cancer (METROS): a phase II, prospective, multicentre, two-arms trial.

Landi L, Chiari R, Tiseo M, D'Incà F, Dazzi C, Chella A, Delmonte A, Bonanno L, Giannarelli D, Cortinovis DL, De Marinis F, Borra G, Morabito A, Gridelli C, Galetta D, Barbieri F, Grossi F, Capelletto E, Minuti G, Mazzoni F, Verusio C, Bria E, Alì G, Bruno R, Proietti A, Fontanini G, Crinò L, Cappuzzo F.

Clin Cancer Res. 2019 Aug 15. pii: clincanres.0994.2019. doi: 10.1158/1078-0432.CCR-19-0994. [Epub ahead of print]

PMID:
31416808
5.

Osimertinib beyond disease progression in T790M EGFR-positive NSCLC patients: a multicenter study of clinicians' attitudes.

Cortellini A, Leonetti A, Catino A, Pizzutillo P, Ricciuti B, De Giglio A, Chiari R, Bordi P, Santini D, Giusti R, De Tursi M, Brocco D, Zoratto F, Rastelli F, Citarella F, Russano M, Filetti M, Marchetti P, Berardi R, Torniai M, Cortinovis D, Sala E, Maggioni C, Follador A, Macerelli M, Nigro O, Tuzi A, Iacono D, Migliorino MR, Banna G, Porzio G, Cannita K, Ferrara MG, Bria E, Galetta D, Ficorella C, Tiseo M.

Clin Transl Oncol. 2019 Aug 7. doi: 10.1007/s12094-019-02193-w. [Epub ahead of print]

PMID:
31392645
6.

Development of Complex Renal Cysts during Crizotinib Treatment and Also during Alectinib Treatment: A Possible Drug Class Effect?

Longo V, Catino AM, Montrone M, Pesola F, Pizzutilo P, Delbene G, Gatti P, Ferrante A, Galetta D.

J Thorac Oncol. 2019 Aug;14(8):e170-e172. doi: 10.1016/j.jtho.2019.03.010. No abstract available.

PMID:
31345340
7.

Final results of the SENECA (SEcond line NintEdanib in non-small cell lung CAncer) trial.

Capelletto E, Migliorino MR, Morabito A, Chiari R, Grossi F, Tiseo M, Costanzo FD, Delmonte A, Romano G, Galetta D, Scotti V, Gregorc V, Pisconti S, Ceresoli GL, Del Conte A, Ciuffreda L, Colantonio I, Bria E, Ricciardi S, Manzo A, Metro G, Morelli AM, Critelli R, Pacchiana MV, Stura I, Migliaretti G, Novello S.

Lung Cancer. 2019 Aug;134:210-217. doi: 10.1016/j.lungcan.2019.06.028. Epub 2019 Jun 27.

PMID:
31319983
8.

Maintenance with lanreotide in small-cell lung cancer expressing somatostatine receptors: A multicenter, randomized, phase 3 trial.

Santo A, Pilotto S, Galetta D, Grossi F, Fasola G, Romano G, Bonanno L, Bearz A, Papi M, Roca E, Catino A, Follador A, Rijavec E, Genova C, Petrillo P, Favaretto A, Giannone L, Milella M, Tortora G, Giannarelli D, Bria E; Italian association FONICAP (Operative National Interdisciplinary Force against Lung Cancer).

Lung Cancer. 2019 Aug;134:121-126. doi: 10.1016/j.lungcan.2019.06.011. Epub 2019 Jun 11.

PMID:
31319970
9.

The therapeutic potential of mesenchymal stem cells in lung cancer: benefits, risks and challenges.

Cortes-Dericks L, Galetta D.

Cell Oncol (Dordr). 2019 Jun 28. doi: 10.1007/s13402-019-00459-7. [Epub ahead of print] Review.

PMID:
31254169
10.

Breath Analysis: A Systematic Review of Volatile Organic Compounds (VOCs) in Diagnostic and Therapeutic Management of Pleural Mesothelioma.

Catino A, de Gennaro G, Di Gilio A, Facchini L, Galetta D, Palmisani J, Porcelli F, Varesano N.

Cancers (Basel). 2019 Jun 14;11(6). pii: E831. doi: 10.3390/cancers11060831. Review.

11.

Molecular Characterization of a Long-Term Survivor Double Metastatic Non-Small Cell Lung Cancer and Pancreatic Ductal Adenocarcinoma Treated with Gefitinib in Combination with Gemcitabine Plus Nab-Paclitaxel and mFOLFOX6 as First and Second Line Therapy.

Brunetti O, Badalamenti G, De Summa S, Calabrese A, Argentiero A, Fucci L, Longo V, Galetta D, Perrotti PMS, Pinto R, Petriella D, Danza K, Tommasi S, Leonetti F, Silvestris N.

Cancers (Basel). 2019 May 29;11(6). pii: E749. doi: 10.3390/cancers11060749.

12.

Tobacco control in Europe: A review of campaign strategies for teenagers and adults.

Bafunno D, Catino A, Lamorgese V, Pizzutilo P, Di Lauro A, Petrillo P, Lapadula V, Mastrandrea A, Ricci D, Galetta D.

Crit Rev Oncol Hematol. 2019 Jun;138:139-147. doi: 10.1016/j.critrevonc.2019.01.022. Epub 2019 Apr 2. Review.

PMID:
31092369
13.

Computed Tomography-Guided Percutaneous Radiotracer Localization and Resection of Indistinct/Small Pulmonary Lesions.

Galetta D, Rampinelli C, Funicelli L, Casiraghi M, Grana C, Bellomi M, Spaggiari L.

Ann Thorac Surg. 2019 Sep;108(3):852-858. doi: 10.1016/j.athoracsur.2019.03.102. Epub 2019 May 7.

PMID:
31075251
14.

Italian Cohort of Nivolumab Expanded Access Program in Squamous Non-Small Cell Lung Cancer: Results from a Real-World Population.

Crinò L, Bidoli P, Delmonte A, Grossi F, De Marinis F, Ardizzoni A, Vitiello F, Lo Russo G, Parra HS, Cortesi E, Cappuzzo F, Calabrò L, Tiseo M, Turci D, Gamucci T, Antonelli P, Morabito A, Chella A, Giannarelli D, Galetta D.

Oncologist. 2019 Apr 17. pii: theoncologist.2018-0737. doi: 10.1634/theoncologist.2018-0737. [Epub ahead of print]

PMID:
30996007
15.

New and old biomarkers in the differential diagnosis of lung cancer: Pro-gastrin-releasing peptide in comparison with neuron-specific enolase, carcinoembryonic antigen, and CYFRA 21-1.

Mauro C, Passerini R, Spaggiari L, Galetta D, Radice D, Lentati P, Sandri MT.

Int J Biol Markers. 2019 Jun;34(2):163-167. doi: 10.1177/1724600819834235. Epub 2019 Apr 17.

PMID:
30994045
16.

Strategies to Improve Cancer Immune Checkpoint Inhibitors Efficacy, Other Than Abscopal Effect: A Systematic Review.

Longo V, Brunetti O, Azzariti A, Galetta D, Nardulli P, Leonetti F, Silvestris N.

Cancers (Basel). 2019 Apr 15;11(4). pii: E539. doi: 10.3390/cancers11040539. Review.

17.

The Presence of Concomitant Mutations Affects the Activity of EGFR Tyrosine Kinase Inhibitors in EGFR-Mutant Non-Small Cell Lung Cancer (NSCLC) Patients.

Rachiglio AM, Fenizia F, Piccirillo MC, Galetta D, Crinò L, Vincenzi B, Barletta E, Pinto C, Ferraù F, Lambiase M, Montanino A, Roma C, Ludovini V, Montagna ES, De Luca A, Rocco G, Botti G, Perrone F, Morabito A, Normanno N.

Cancers (Basel). 2019 Mar 10;11(3). pii: E341. doi: 10.3390/cancers11030341.

18.

BRAF Mutant NSCLC and Immune Checkpoint Inhibitors: Results From a Real-World Experience.

Rihawi K, Giannarelli D, Galetta D, Delmonte A, Giavarra M, Turci D, Garassino M, Tiseo M, Barbieri F, Panni S, Ardizzoni A.

J Thorac Oncol. 2019 Mar;14(3):e57-e59. doi: 10.1016/j.jtho.2018.11.036. No abstract available.

PMID:
30782386
19.

BRMS1 expression in resected lung adenocarcinoma.

Galetta D, Pizzutilo P, Longo V.

Transl Lung Cancer Res. 2018 Dec;7(Suppl 4):S364-S366. doi: 10.21037/tlcr.2018.09.20. No abstract available.

20.

Beyond the boundaries: Surgical repair of apical parietal pleural hernia.

Galetta D, Spaggiari L.

J Thorac Cardiovasc Surg. 2018 Nov 15. pii: S0022-5223(18)32959-3. doi: 10.1016/j.jtcvs.2018.11.017. [Epub ahead of print] No abstract available.

PMID:
30553596
21.

Discordance between FISH, IHC, and NGS Analysis of ALK Status in Advanced Non-Small Cell Lung Cancer (NSCLC): a Brief Report of 7 Cases.

Scattone A, Catino A, Schirosi L, Caldarola L, Tommasi S, Lacalamita R, Montagna ES, Galetta D, Serio G, Zito FA, Mangia A.

Transl Oncol. 2019 Feb;12(2):389-395. doi: 10.1016/j.tranon.2018.11.006. Epub 2018 Dec 4.

22.

A rationale multidisciplinary approach for treatment of esophageal and gastroesophageal junction cancer: Accurate review of management and perspectives.

Chiappa A, Andreoni B, Dionigi R, Spaggiari L, Foschi D, Polvani G, Orecchia R, Fazio N, Pravettoni G, Cossu ML, Galetta D, Venturino M, Ferrari C, Macone L, Crosta C, Bonanni B, Biffi R.

Crit Rev Oncol Hematol. 2018 Dec;132:161-168. doi: 10.1016/j.critrevonc.2018.10.002. Epub 2018 Oct 13. Review.

PMID:
30447922
23.

Pneumonectomy in Stage IIIA-N2 NSCLC: Should It Be Considered After Neoadjuvant Chemotherapy?

Casiraghi M, Guarize J, Sandri A, Maisonneuve P, Brambilla D, Romano R, Galetta D, Petrella F, Gasparri R, Gridelli C, De Marinis F, Spaggiari L.

Clin Lung Cancer. 2019 Mar;20(2):97-106.e1. doi: 10.1016/j.cllc.2018.10.005. Epub 2018 Oct 24.

PMID:
30446406
24.

Diagnostic and Therapeutic Implications of Pulmonary Lymphoma Associated With Nodular Amyloidosis.

Filippi N, Diotti C, Donghi SM, Galetta D, Sedda G, Sandri A, De Camilli E, Guarize J, Spaggiari L.

Ann Thorac Surg. 2019 May;107(5):e325-e327. doi: 10.1016/j.athoracsur.2018.09.037. Epub 2018 Nov 2.

PMID:
30395852
25.

Efficacy of nivolumab in pre-treated non-small-cell lung cancer patients harbouring KRAS mutations.

Passiglia F, Cappuzzo F, Alabiso O, Bettini AC, Bidoli P, Chiari R, Defferrari C, Delmonte A, Finocchiaro G, Francini G, Gelsomino F, Giannarelli D, Giordano M, Illiano A, Livi L, Martelli O, Natoli C, Puppo G, Ricevuto E, Roca E, Turci D, Galetta D.

Br J Cancer. 2019 Jan;120(1):57-62. doi: 10.1038/s41416-018-0234-3. Epub 2018 Oct 31.

PMID:
30377342
26.

Video-Thoracoscopic Management of Postpneumonectomy Empyema.

Galetta D, Spaggiari L.

Thorac Cardiovasc Surg. 2018 Nov;66(8):701-706. doi: 10.1055/s-0038-1667008. Epub 2018 Aug 7.

PMID:
30086571
27.

Pleural catheters after thoracoscopic treatment of malignant pleural effusion: a randomized comparative study on quality of life.

Petrella F, Maisonneuve P, Borri A, Casiraghi M, Donghi S, Durkovic S, Filippi N, Galetta D, Gasparri R, Guarize J, Lo Iacono G, Mariolo AV, Tessitore A, Spaggiari L.

J Thorac Dis. 2018 May;10(5):2999-3004. doi: 10.21037/jtd.2018.05.49.

28.

Breast Metastasis from Malignant Pleural Mesothelioma: A Rare Challenging Entity.

Catino A, La Forgia D, Scattone A, Dentamaro R, Lapadula V, Galetta D.

J Thorac Oncol. 2018 Jul;13(7):e117-e118. doi: 10.1016/j.jtho.2018.02.028. No abstract available.

29.

Italian Nivolumab Expanded Access Program in Nonsquamous Non-Small Cell Lung Cancer Patients: Results in Never-Smokers and EGFR-Mutant Patients.

Garassino MC, Gelibter AJ, Grossi F, Chiari R, Soto Parra H, Cascinu S, Cognetti F, Turci D, Blasi L, Bengala C, Mini E, Baldini E, Quadrini S, Ceresoli GL, Antonelli P, Vasile E, Pinto C, Fasola G, Galetta D, Macerelli M, Giannarelli D, Lo Russo G, de Marinis F.

J Thorac Oncol. 2018 Aug;13(8):1146-1155. doi: 10.1016/j.jtho.2018.04.025. Epub 2018 May 3.

30.

Robotic-assisted thymectomy for early-stage thymoma: a propensity-score matched analysis.

Casiraghi M, Galetta D, Borri A, Tessitore A, Romano R, Brambilla D, Maisonneuve P, Spaggiari L.

J Robot Surg. 2018 Dec;12(4):719-724. doi: 10.1007/s11701-018-0816-3. Epub 2018 Apr 28.

PMID:
29705833
31.

Robotic Hybrid Approach for an Anterior Pancoast Tumor in a Severely Obese Patient.

Mariolo AV, Casiraghi M, Galetta D, Spaggiari L.

Ann Thorac Surg. 2018 Sep;106(3):e115-e116. doi: 10.1016/j.athoracsur.2018.03.013. Epub 2018 Apr 12.

PMID:
29654726
32.

Ten Years' Experience in Robotic-Assisted Thoracic Surgery for Early Stage Lung Cancer.

Casiraghi M, Galetta D, Borri A, Tessitore A, Romano R, Diotti C, Brambilla D, Maisonneuve P, Spaggiari L.

Thorac Cardiovasc Surg. 2019 Oct;67(7):564-572. doi: 10.1055/s-0038-1639575. Epub 2018 Apr 1.

PMID:
29605962
33.

Emergency drain for post pneumonectomy bronchopleural fistula: a drain placement technique based on the siphon principle.

Petrella F, Sandri A, Rizzo S, Borri A, Galetta D, Gasparri R, Spaggiari L.

J Thorac Dis. 2018 Jan;10(1):468-471. doi: 10.21037/jtd.2017.11.145.

34.

Early and Long-Term Results of Tracheal Sleeve Pneumonectomy for Lung Cancer After Induction Therapy.

Galetta D, Spaggiari L.

Ann Thorac Surg. 2018 Apr;105(4):1017-1023. doi: 10.1016/j.athoracsur.2017.11.052. Epub 2017 Dec 23.

PMID:
29277671
35.

Chemotherapy-induced nausea and vomiting (CINV) in patients with advanced lung cancer during the first-line treatment: assessment by physicians, nurses, and patients from an Italian multicenter survey.

Carnio S, Galetta D, Scotti V, Cortinovis DL, Antonuzzo A, Pisconti S, Rossi A, Martelli O, Cecere FL, Lunghi A, Del Conte A, Montagna ES, Topulli J, Pelizzoni D, Rapetti SG, Gianetta M, Pacchiana MV, Pegoraro V, Cataldo N, Bria E, Novello S.

Support Care Cancer. 2018 Jun;26(6):1841-1849. doi: 10.1007/s00520-017-4004-1. Epub 2017 Dec 21.

PMID:
29270827
36.

Effect of Contract Research Organization Bureaucracy in Clinical Trial Management: A Model From Lung Cancer.

Gobbini E, Pilotto S, Pasello G, Polo V, Di Maio M, Arizio F, Galetta D, Petrillo P, Chiari R, Matocci R, Di Costanzo A, Di Stefano TS, Aglietta M, Cagnazzo C, Sperduti I, Bria E, Novello S.

Clin Lung Cancer. 2018 Mar;19(2):191-198. doi: 10.1016/j.cllc.2017.10.012. Epub 2017 Oct 28.

PMID:
29153968
37.

Ceritinib compassionate use for patients with crizotinib-refractory, anaplastic lymphoma kinase-positive advanced non-small-cell lung cancer.

Metro G, Passaro A, Lo Russo G, Bonanno L, Giusti R, Gregorc V, Capelletto E, Martelli O, Cecere FL, Giannarelli D, Luciani A, Bearz A, Tuzi A, Scotti V, Tonini G, Galetta D, Carta A, Soto Parra H, Rebonato A, Morabito A, Chiari R.

Future Oncol. 2018 Feb;14(4):353-361. doi: 10.2217/fon-2017-0441. Epub 2017 Nov 14.

PMID:
29135281
38.

Bronchopleural Fistula After Pneumonectomy: Risk Factors and Management, Focusing on Open-Window Thoracostomy.

Mazzella A, Pardolesi A, Maisonneuve P, Petrella F, Galetta D, Gasparri R, Spaggiari L.

Semin Thorac Cardiovasc Surg. 2018 Spring;30(1):104-113. doi: 10.1053/j.semtcvs.2017.10.003. Epub 2017 Nov 3.

PMID:
29109057
39.

New stapling devices in robotic surgery.

Galetta D, Casiraghi M, Pardolesi A, Borri A, Spaggiari L.

J Vis Surg. 2017 Apr 10;3:45. doi: 10.21037/jovs.2017.02.03. eCollection 2017.

40.

Diagnostic biomarkers for lung cancer prevention.

Gasparri R, Romano R, Sedda G, Borri A, Petrella F, Galetta D, Casiraghi M, Spaggiari L.

J Breath Res. 2018 Feb 6;12(2):027111. doi: 10.1088/1752-7163/aa9386. Review.

PMID:
29033394
41.

Molecular profiling in Italian patients with advanced non-small-cell lung cancer: An observational prospective study.

Gobbini E, Galetta D, Tiseo M, Graziano P, Rossi A, Bria E, Di Maio M, Rossi G, Gregorc V, Riccardi F, Scotti V, Ceribelli A, Buffoni L, Delmonte A, Franchina T, Migliorino MR, Cortinovis D, Pisconti S, Bordi P, Catino A, Maiello E, Arizio F, Novello S; other Co-Authors.

Lung Cancer. 2017 Sep;111:30-37. doi: 10.1016/j.lungcan.2017.06.009. Epub 2017 Jun 16.

PMID:
28838394
42.

WITHDRAWN: Bronchopleural fistula after pneumonectomy: Risk factors and management, focusing on open window thoracostomy.

Mazzella A, Pardolesi A, Maisonneuve P, Petrella F, Galetta D, Gasparri R, Spaggiari L.

J Thorac Cardiovasc Surg. 2017 Jun 12. pii: S0022-5223(17)31189-3. doi: 10.1016/j.jtcvs.2017.05.105. [Epub ahead of print]

PMID:
28697892
43.

Outcomes of First-Generation EGFR-TKIs Against Non-Small-Cell Lung Cancer Harboring Uncommon EGFR Mutations: A Post Hoc Analysis of the BE-POSITIVE Study.

Pilotto S, Rossi A, Vavalà T, Follador A, Tiseo M, Galetta D, Morabito A, Di Maio M, Martelli O, Caffo O, Piovano PL, Cortinovis D, Zilembo N, Casartelli C, Banna GL, Ardizzoia A, Barzelloni ML, Bearz A, Genestreti G, Mucciarini C, Filipazzi V, Menis J, Rizzo E, Barbieri F, Rijavec E, Cecere F, Spitaleri G, Bria E, Novello S.

Clin Lung Cancer. 2018 Jan;19(1):93-104. doi: 10.1016/j.cllc.2017.05.016. Epub 2017 Jun 1.

PMID:
28645631
44.

Induction chemotherapy, extrapleural pneumonectomy and adjuvant radiotherapy for malignant pleural mesothelioma.

Casiraghi M, Maisonneuve P, Brambilla D, Solli P, Galetta D, Petrella F, Piperno G, De Marinis F, Spaggiari L.

Eur J Cardiothorac Surg. 2017 Nov 1;52(5):975-981. doi: 10.1093/ejcts/ezx122.

PMID:
28482086
45.

Final data of an Italian multicentric survey about counseling for smoking cessation in patients with diagnosis of a respiratory disease.

Capelletto E, Rapetti SG, Demichelis S, Galetta D, Catino A, Ricci D, Moretti AM, Bria E, Pilotto S, Bruno A, Valmadre G, Bandelli GP, Trisolini R, Gianetta M, Pacchiana MV, Vallone S, Novello S.

Clin Respir J. 2018 Mar;12(3):1150-1159. doi: 10.1111/crj.12644. Epub 2017 May 10.

PMID:
28466511
46.

Economic burden of patients affected by non-small cell lung cancer (NSCLC): the LIFE study.

Migliorino MR, Santo A, Romano G, Cortinovis D, Galetta D, Alabiso O, Cartenì G, Vari S, Fasola G, Pazzola A, Giuffrida D, Zaniboni A, Caprioli A, Longo F, Acciai V, de Marinis F.

J Cancer Res Clin Oncol. 2017 May;143(5):783-791. doi: 10.1007/s00432-016-2326-x. Epub 2017 Feb 18.

PMID:
28215027
47.

Patients' Attitudes and Physicians' Perceptions Toward Maintenance Therapy for Advanced Non-Small-cell Lung Cancer: A Multicenter Italian Survey.

Pacchiana MV, Capelletto E, Carnio S, Gridelli C, Rossi A, Galetta D, Montagna ES, Bordi P, Ceribelli A, Cortinovis D, Scotti V, Martelli O, Valmadre G, Del Conte A, Miccianza A, Morena R, Rosetti F, Di Maio M, Ostacoli L, Novello S.

Clin Lung Cancer. 2017 Jul;18(4):381-387. doi: 10.1016/j.cllc.2016.10.002. Epub 2016 Nov 22.

PMID:
27965013
48.

Intercalated Chemotherapy and Epidermal Growth Factor Receptor Inhibitors for Patients With Advanced Non-Small-cell Lung Cancer: A Systematic Review and Meta-analysis.

La Salvia A, Rossi A, Galetta D, Gobbini E, De Luca E, Novello S, Di Maio M.

Clin Lung Cancer. 2017 Jan;18(1):23-33.e1. doi: 10.1016/j.cllc.2016.08.006. Epub 2016 Oct 28. Review.

PMID:
27876230
49.

A phase 2 randomized study of TAS-102 versus topotecan or amrubicin in patients requiring second-line chemotherapy for small cell lung cancer refractory or sensitive to frontline platinum-based chemotherapy.

Scagliotti G, Nishio M, Satouchi M, Valmadre G, Niho S, Galetta D, Cortinovis D, Benedetti F, Yoshihara E, Makris L, Inoue A, Kubota K.

Lung Cancer. 2016 Oct;100:20-23. doi: 10.1016/j.lungcan.2016.06.023. Epub 2016 Jun 27.

PMID:
27597276
50.

Glasgow Prognostic Score Class 2 Predicts Prolonged Intensive Care Unit Stay in Patients Undergoing Pneumonectomy.

Petrella F, Radice D, Casiraghi M, Gasparri R, Borri A, Guarize J, Galetta D, Venturino M, Spaggiari L.

Ann Thorac Surg. 2016 Dec;102(6):1898-1904. doi: 10.1016/j.athoracsur.2016.05.111. Epub 2016 Aug 20.

PMID:
27553499

Supplemental Content

Loading ...
Support Center